<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Recommended wait time for SOT candidates with a prior history of prostate cancer</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Recommended wait time for SOT candidates with a prior history of prostate cancer</h1>
<div class="graphic"><div class="figure"><div class="ttl">Recommended wait time for SOT candidates with a prior history of prostate cancer</div><div class="cntnt"><table cellspacing="0"><colgroup width="27%"></colgroup><colgroup width="19%"></colgroup><colgroup span="2" width="27%"></colgroup> <tbody> <tr> <td class="subtitle1">Risk/stage</td> <td class="subtitle1">Survival</td> <td class="subtitle1">Time interval to transplant</td> <td class="subtitle1">Additional considerations</td> </tr> <tr> <td><strong>Very low risk</strong></td> <td>&lt;1% risk of mets/death over 15 years</td> <td>None</td> <td>Surveillance is strongly recommended</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>PSA &lt;10 ng/mL</li> </ul> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td> <ul class="decimal_heading"> <li>3 or fewer cores of Gleason 6 (grade group 1); no greater than 50% of individual core</li> </ul> </td> <td> </td> <td> </td> <td>Extenuating circumstances may require treatment</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>T1c to T2a</li> </ul> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td><strong>Low risk</strong></td> <td>~2 to 3% risk of mets/death over 15 years</td> <td>None</td> <td>Surveillance is strongly recommended</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>PSA &lt;10 ng/mL</li> </ul> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td> <ul class="decimal_heading"> <li>Gleason 6 (not meeting very low-risk criteria)</li> </ul> </td> <td> </td> <td> </td> <td>Extenuating circumstances may require treatment</td> </tr> <tr> <td> <ul class="decimal_heading"> <li>T1c to T2a</li> </ul> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td><strong>Low-volume intermediate risk</strong> <ul class="decimal_heading"> <li>One of the following criteria: PSA &gt;10 ng/mL, Gleason 7 (grade group 2 or 3), T2b</li> </ul> </td> <td>&lt;5% risk of mets/death over 15 years</td> <td> <p>If surveillance, no wait time</p> If treatment initiated, and <a href="https://www.mskcc.org/nomograms" target="_blank">nomogram</a> predicts cancer-specific death over the next 15 years &lt;10%, no wait time </td> <td>Surveillance or treatment, depending on patient and cancer characteristics</td> </tr> <tr> <td><strong>High-volume intermediate risk, high risk, or very high risk</strong> <ul class="decimal_heading"> <li>PSA &gt;20 ng/mL or high-volume Gleason 7 or any Gleason 8 to 10, T3</li> </ul> </td> <td>20 to 70% risk of mets/death over 15 years</td> <td>If treatment initiated, and <a href="https://www.mskcc.org/nomograms" target="_blank">nomogram</a> predicts cancer-specific death over the next 15 years &lt;10%, no wait time</td> <td>Treatment</td> </tr> <tr> <td><strong>Metastatic castration-sensitive</strong></td> <td>Median survival ~5 to 6 years</td> <td>If stable disease for 2 years with prolonged estimated life expectancy, may consider transplant</td> <td>Best systemic therapy ± local treatment</td> </tr> <tr> <td><strong>Metastatic castration-resistant</strong></td> <td>Median survival 2 to 3 years</td> <td>Not a SOT candidate</td> <td>Best systemic therapy</td> </tr> </tbody></table></div><div class="graphic_footnotes">PSA: prostate specific antigen.</div><div class="graphic_reference">From: Al-Adra DP, Hammel L, Roberts, J, et al. Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement. Am J Transplant 2021; 21:460. <a href="https://onlinelibrary.wiley.com/doi/10.1111/ajt.16318" target="_blank">https://onlinelibrary.wiley.com/doi/10.1111/ajt.16318</a>. Copyright © 2021 John Wiley &amp; Sons Ltd. Reproduced with permission of John Wiley &amp; Sons Inc. This image has been provided by or is owned by Wiley. Further permission is needed before it can be downloaded to PowerPoint, printed, shared or emailed. Please contact Wiley's permissions department either via email: <a href="/cdn-cgi/l/email-protection#9cecf9eef1f5efeff5f3f2efdcebf5f0f9e5b2fff3f1" target="_blank"><span class="__cf_email__" data-cfemail="d2a2b7a0bfbba1a1bbbdbca192a5bbbeb7abfcb1bdbf">[email protected]</span></a> or use the RightsLink service by clicking on the 'Request Permission' link accompanying this article on Wiley Online Library (<a href="https://onlinelibrary.wiley.com/" target="_blank">https://onlinelibrary.wiley.com/</a>).</div><div id="graphicVersion">Graphic 135216 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
